We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.


Revolutionise the Clinical Laboratory with Streamlined Workflow for Improved Productivity

Want a FREE PDF version of this product news?

Complete the form below and we will email you a PDF version of "Revolutionise the Clinical Laboratory with Streamlined Workflow for Improved Productivity"

Listen with
Register for free to listen to this article
Thank you. Listen to this article using the player above.
Read time:

“The DxN VERIS Molecular Diagnostics System is designed to revolutionise the clinical laboratory with LEAN workflow and improved sample turn-around time,” said Arnd Kaldowski, president, Beckman Coulter Diagnostics. “The system’s true single sample random access empowers laboratories to perform viral load tests whenever they want, at a time that suits them—ultimately helping physicians make faster clinical decisions and  positively impacting the patient pathway. 

“The robust DxN VERIS can run up to 20 assays at any time,” Kaldowski continues.  “This enables laboratories to optimise workflows and staffing productivity, freeing up time, for example, to bring additional and new testing in-house, for laboratory service expansion and to increase reference site revenue potential.” 


With LEAN principles at its core, DxN VERIS combines sample prep, nucleic acid extraction, reaction setup, real-time PCR amplification, detection and results interpretation in one instrument, streamlining workflow for improved productivity.  “With DxN VERIS we have significantly reduced the need for manual intervention, enabling labs to go from a sample to auto-verified result in just 70 minutes,” said Richard Creager, senior vice president, Molecular Diagnostics Business Unit and chief scientific officer at Beckman Coulter Diagnostics.

Fully CE-marked, the system is available with assays for Human Immunodeficiency Virus (HIV-1), Hepatitis C Virus (HCV), Hepatitis B Virus (HBV) and Human Cytomegalovirus (CMV). Further menu expansion will follow with many other assays currently in development. 

DxN VERIS assays are supplied in a unique, single cartridge system so, unlike traditional batch-plate systems, there are no empty wells, reducing wastage and consumable costs. With the DxN VERIS Molecular Diagnostics System, all necessary consumables and reagents are on-board, so there is no lengthy set-up and tests can be up and running in less than 10 minutes.